Skip to content

Vitamin D Deficiency and Pregnancy Rates in Women Undergoing Frozen Embryo Transfer

Vitamin D Deficiency and Pregnancy Rates in Women Undergoing Frozen Embryo Transfer. A Prospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01985672
Enrollment
280
Registered
2013-11-15
Start date
2013-08-31
Completion date
2015-07-31
Last updated
2015-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

Infertility

Brief summary

Vitamin D receptors are present and differently expressed in murine endometrium and ovary throughout the estrous cycle , whereas knock-out experiments have shown that vitamin D receptor null mice experience uterine hypoplasia and impaired folliculogenesis. Only few retrospective studies examining the role of vitamin D levels in infertile patients have been published up to date, whereas results are strongly contradictory, with some supporting that maternal vitamin D deficiency is associated with lower pregnancy rates and others demonstrating that vitamin D deficiency does not affect final reproductive outcome. Finally, a recent retrospective study postulated that vitamin D deficiency may negatively affect pregnancy rates with an effect mediated through the endometrium, given that vitamin D deficiency was not correlated with ovarian stimulation characteristics or with markers of embryo quality in this study. In order to examine a potential negative effect of vitamin D deficiency on pregnancy rates, mediated through the endometrium, the aim of the current study was to examine the impact of vitamin D levels on pregnancy rates only in an infertile population undergoing embryo transfer of frozen-thawed embryos.

Interventions

PROCEDUREFrozen embryo transfer

Embryo transfer of frozen/thawed embryos after IVF/ICSI

Sponsors

Universitair Ziekenhuis Brussel
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* All women undergoing a frozen ET with 1 or 2 Day 5 (blastocyst stage) embryo * Age 18-39

Exclusion criteria

* Women \> or = 40 years old * IVM ET * Uterine abnormalities

Design outcomes

Primary

MeasureTime frameDescription
Clinical pregnancy4 weeks after embryo transferThe presence of intrauterine gestational sac at 7 weeks of gestation

Secondary

MeasureTime frameDescription
Biochemical pregnancy2 weeks after embryo transferPositive pregnancy test 2 weeks after embryo transfer

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026